PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysisFrancesco Passiglia, Antonio Russo, Viviana Bazan et al.|Oncotarget|2016Cited by 166
The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung CancerValerio Gristina, Viviana Bazan|Pharmaceuticals|2020Cited by 74